The anatomic pathology market is estimated to grow from USD 33.0 billion in 2019 to USD 44.4 billion by 2024, at a CAGR of 6.1%.
Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab) – Global Forecast to 2024
However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper market growth to a certain extent during the forecast period.
Request a Sample Report of Anatomic Pathology Market at:: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145
The Anatomic Pathology Market is Segmented on:
1. Product & Service
2. Consumables
3. Application
4. End User
Services segment to witness the highest growth during the forecast period
By product & service, the market is segmented into services, instruments, and consumables. The services segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period.
Disease diagnosis segment accounted for the largest share of the anatomic pathology market, by application, in 2018
Based on application, the market is segmented into disease diagnosis and medical research. The market for disease diagnosis is further segmented into cancer and other diseases. In 2018, the disease diagnosis segment accounted for the largest market share.
Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
The report claims to split the Regional Scope of the Focused anatomic pathology Market into
North America (US and Canada)
Europe (Germany, France, UK, Spain, RoE & Italy)
Asia-Pacific (China, Japan, India and Rest of Asia Pacific)
Rest of World (Latin America, Middle East & Africa)
The Geographical Landscape of the Market Include:
In 2018, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the market in North America.
Some key players mentioned in the research report are:
Prominent players in anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Thermo Fisher Scientific (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (Italy), and BioGenex Laboratories (US).
F. Hoffmann-La Roche Ltd. (Switzerland) is the leading player in the market. The company offers a full range of consumables that are used for the diagnosis of various types of diseases, including cancers of the lung, breast, and blood. The company focuses on organic growth strategies to maintain its leading position in the market. For instance, in 2018, the company received CE approval for its BenchMark ULTRA Plus Staining System. Similarly, in April 2017, the company received FDA approval for its CINtec Histology test.
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com
